| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.3M | -89.9% |
| R&D Expense | $320.7M | -17.2% |
| SG&A Expense | $73.0M | -4.2% |
| Operating Income | -$466.6M | -109.7% |
| Pre-tax Income | -$362.7M | -140.6% |
| Income Tax | $3.6M | +24.2% |
| Net Income | -$366.3M | -138.4% |
| EPS (Basic) | -$4.34 | -123.7% |
| EPS (Diluted) | -$4.34 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $298.3M | -23.4% |
| Short-term Investments | $1.61B | +23.1% |
| Accounts Receivable | $25.0M | -87.5% |
| Current Assets | $1.94B | +1.5% |
| Total Assets | $2.24B | +0.6% |
| Current Liabilities | $87.8M | -19.3% |
| Total Liabilities | $310.0M | -10.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.8M | +45.2% |
| Capital Expenditures | $1.9M | -79.9% |
| Investing Cash Flow | -$280.5M | -174.9% |
| Financing Cash Flow | $332.0M | +429.8% |
| Free Cash Flow | -$144.7M | +46.4% |
| -123.7% |
| Stockholders' Equity |
| $1.93B |
| +2.6% |